Peking Union Lawke Biomedical Development Limited (PUL) is a joint-venture enterprise that was set up by Lawke Health International Limited and CAMS & PUMC. PUL integrates the functions of medical care, education, research and entrepreneurship. Lawke Health International Limited bridges the United States and China, with a goal to commercialize biotechnologies in the health-related fields. PUL is co-located with CCLD, and the CEO of PUL serves also as the Director of CCLD. PUL will facilitate the mission of Lawke Health International Limited in China to realize a synergy of technologies, products and services with utterly new concepts. PUL aims to set up a franchised clinical testing lab, to introduce and assimilate advanced laboratory testing technologies, and to develop new laboratory testing products to facilitate clinical diagnosis and treatment. Through consulting and training programs, PUL will strive to promote advanced clinical laboratory quality systems and managerial skills in order to further the development of clinical laboratories in Chinese hospitals. Taking clinical laboratory testing as its core service, PUL will endeavor to initiate new services in the field of medical care and public health, thus contributing to the continual improvement of people’s health
Suggested by CCLD's Academic Committee, the research and development goals and range tentatively include:
1. The application of LC/MS and ICP/MS in clinical laboratory testing: a) Doping tests for 2008 Olympic Game in Beijing, b) Research in laboratory testing methods and treatment plans concerning organic acid, amino acid, and fatty acid in genetic metabolic disorders, c) Element analysis, d) Projects and exploitation in clinical therapeutic drug monitoring. 2. The application and exploitation of gene and protein chips used in clinical laboratory test. 3. The application of pathological and molecular pathological technologies in disease diagnosis and classification. 4. Reference test method establishment and reference material verification. 5. Cancer marker test and anti-cancer gene drug monitoring. 6. Health quality assessment and the preventive measures as well as anti-aging research. 7. Growth and development examination of children and adolescents. 8. Research in clinical emergency tests for public health. 9. The development of community medical treatment system supported by clinical laboratory testing. 10. Projects of national urgent needs and governmental support.